发明名称 Transfer hydrogenation of cyclopamine analogs
摘要 Provided herein is a process for the transfer-hydrogenation of ketone analogs of members of the jervine type of Veratrum alkaloids, such as cyclopamine. Also provided herein are novel ruthenium transfer-hydrogenation catalysts.
申请公布号 US9394313(B2) 申请公布日期 2016.07.19
申请号 US201113232851 申请日期 2011.09.14
申请人 Infinity Pharmaceuticals, Inc. 发明人 Genov Daniel G.;Austad Brian C.;White Brian H.
分类号 C07D491/048;C07F17/02 主分类号 C07D491/048
代理机构 McDermott Will & Emery LLP 代理人 Evans Susan T.;McDermott Will & Emery LLP
主权项 1. A process for preparing a compound of formula II-a: or a pharmaceutically acceptable salt form thereof; from a compound of formula I-a: or a pharmaceutically acceptable salt form thereof; wherein: R1 is H or a nitrogen protecting group; the process comprising reacting a compound of formula (I-a) or a pharmaceutically acceptable salt form thereof with a hydrogen donor selected from the group consisting of methanol, ethanol, isopropanol, and t-butanol, in the presence of a ruthenium transfer-hydrogenation catalyst of formula (iii-a): wherein Ra and Rb are both either H or methyl; and Rc is either H or C1-6 alkyl; to thereby provide a compound of formula (ii-a) or a pharmaceutically acceptable salt form thereof in a diastereomeric excess of greater than about 90% to about 99.5%.
地址 Cambridge MA US